Margaux Nair

Margaux Nair

K&L Gates LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Purple is the New Orange: FDA Releases a Purple Book for Biosimilars

On September 9, 2014, the U.S. Food and Drug Administration (“FDA”) published the first edition of the Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or...more

9/16/2014 - Biosimilars BPCIA FDA Pharmaceutical PHSA Popular Purple Book

Abstract Ideas: The Patent Office’s First Take on Alice Corp. v. CLS Bank International

The United States Patent Office periodically issues guidelines for Examiners, often in response to a recent court decision or new statute. These guidelines do not have the force of law, but nevertheless establish the specific...more

7/17/2014 - CLS Bank v Alice Corp Mayo v. Prometheus Patent Applications Patent Examinations Patent Litigation Patent-Eligible Subject Matter Patents Risk Mitigation SCOTUS Software USPTO

U.S. Patent Office Issues Extensive Subject Matter Eligibility Guidelines

The United States Patent Office periodically issues guidance for examiners (“Examiners”), often in response to a recent court decision or new statute. These guidelines do not have the force of law, but nevertheless establish...more

4/15/2014 - Examiners Myriad Patent Applications Patent-Eligible Subject Matter Patents Prometheus USPTO

3 Results
|
View per page
Page: of 1